ADMTronics Unlimited Inc. reported net revenues of $887,498 for the three months ended September 30, 2025, an increase of 5.6% compared to $840,036 for the same period in 2024. For the six months ended September 30, 2025, net revenues were $1,861,173, up 9.6% from $1,697,881 in the prior year. Income from operations for the quarter was $2,553, compared to a loss of $45,858 in the same period last year. For the six-month period, income from operations was $111,787, down from $118,262 last year. The company continues research and development on its Sonotron technology, a non-invasive medical device for musculoskeletal pain, and plans to submit a 510(k) Pre-Market Notification to the FDA for clearance as a Class II prescription medical device.